Brought to you by 
West Pharmaceutical licenses delivery technology to Chiron
14 Apr 2003
Executive Summary
West Pharmaceutical Services has licensed Chiron Vaccines worldwide rights to use its ChiSys nasal drug delivery technology to develop a vaccine for diphtheria and tetanus.
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
- Vaccines
-
Drug Delivery
- Nasal
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
West Pharmaceutical licenses delivery technology to Chiron
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice